Cover Image

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy

Introduction: Prostate cancer is the second leading cause of cancer death among men in the United States. Castration-Resistant Prostate Cancer (CRPC) often develops resistance to androgen deprivation therapy. Resistance in CRPC is often driven by AR variants and glucocorticoid receptor (GR). Thus, d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wing Lam (Author), Mohammad Arammash (Author), Wei Cai (Author), Fulan Guan (Author), Zaoli Jiang (Author), Shwu-Huey Liu (Author), Peikwen Cheng (Author), Yung-Chi Cheng (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)
by: Wing Lam, et al.
Published: (2018)

YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity
by: Wing Lam, et al.
Published: (2023)

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer
by: Yongbao Wei, et al.
Published: (2023)

Effect of dimethoxycurcumin beyond degradation of androgen receptor
by: Wei-Ming Wang, et al.
Published: (2011)

Development and validation of a novel method for simultaneous quantification of enzalutamide, darolutamide and their active metabolites in mice dried blood spots using LC-MS/MS: Application to pharmacokinetic study in mice
by: Neeraj Kumar Saini, et al.
Published: (2018)

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
by: Namrata Khurana, et al.
Published: (2020)

Overexpression of Androgen, Oestrogen and Progesterone Receptors in Skin Lesions of Becker's Naevus
by: Ping Sheng, et al.
Published: (2018)

Apalutamide-induced ichthyosiform eruption
by: Christian Ciolfi, et al.
Published: (2023)

Androgen receptor expression in hypospadias
by: Dhanvanth Rajesh Balaji, et al.
Published: (2020)

Androgen receptor coordinates muscle metabolic and contractile functions
by: Kamar Ghaibour, et al.
Published: (2023)

Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids
by: David Levitt
Published: (2024)

Glucocorticoids Decrease Astrocyte Numbers by Reducing Glucocorticoid Receptor Expression In Vitro and In Vivo
by: Kazuhiro Unemura, et al.
Published: (2012)

Psoriatic Skin Lesions after Apalutamide Treatment
by: Fumi Miyagawa, et al.
Published: (2022)

Splice variants of androgen receptor and prostate cancer
by: Orazio Caffo, et al.
Published: (2016)

Anti-inflammatory Effect of Theophylline in Rats and Its Involvement of the Glucocorticoid-Glucocorticoid Receptor System
by: Shigekazu Watanabe, et al.
Published: (2008)

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7
by: Balaji Chandrasekaran, et al.
Published: (2023)

Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis
by: Scheplyagina Larisa A, et al.
Published: (2011)

Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome
by: Megan Lynn, et al.
Published: (2018)

Expression of Androgen Receptor in Human Placentas from Normal and Preeclamptic Pregnancies
by: Te-Yao Hsu, et al.
Published: (2009)

Androgen increases klotho expression via the androgen receptor-mediated pathway to induce GCs apoptosis
by: Xin Zeng, et al.
Published: (2023)

Role of Glucocorticoid Receptor in the Regulation of Cellular Sensitivity to Irinotecan Hydrochloride
by: Takanori Akagi, et al.
Published: (2009)

BCLI GENE POLYMORPHISM OF GLUCOCORTICOID RECEPTOR IN CHILDREN WITH BRONCHIAL ASTHMA
by: M.V. Zhdanova
Published: (2006)

BCLI GENE POLYMORPHISM OF GLUCOCORTICOID RECEPTOR IN CHILDREN WITH BRONCHIAL ASTHMA
by: M.V. Zhdanova
Published: (2006)

Molecular regulation of urea cycle function by the liver glucocorticoid receptor
by: Jürgen G. Okun, et al.
Published: (2015)

Androgen receptor, oxidative stress and inflammation at the crossroads of skin diseases
by: Yiumo Michael Chan, et al.
Published: (2022)

Androgen receptor overexpression in prostate cancer in type 2 diabetes
by: Stefan Zoltán Lutz, et al.
Published: (2018)

Practical implications of androgen receptor inhibitors for prostate cancer treatment
by: Fabio Campodonico, et al.
Published: (2024)

LPS regulates the expression of glucocorticoid receptor α and β isoforms and induces a selective glucocorticoid resistance in vitro
by: Maria Luisa Molina, et al.
Published: (2017)

An unexpected, mild phenotype of glucocorticoid resistance associated with glucocorticoid receptor gene mutation case report and review of the literature
by: Ágnes Molnár, et al.
Published: (2018)

The expert system of genotype discrimination for D5S818 locus based on near-infrared spectroscopyâprincipal discriminant variate
by: Zai-Zhen Wu, et al.
Published: (2012)

A selective androgen receptor modulator SARM‐2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys
by: Megumi Morimoto, et al.
Published: (2020)

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system
by: Zhihong Fang, et al.
Published: (2023)

Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review
by: Rogliani P, et al.
Published: (2020)

Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations
by: Javier Gil-Lianes, et al.
Published: (2024)

Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
by: Nora A. Alkhudair
Published: (2019)

[Translated article] RF-Adverse Skin Reaction to Apalutamide: An Emerging Effect
by: M. Pons Benavent, et al.
Published: (2023)

Androgen receptor expression in the rat prostate is down-regulated by dietary phytoestrogens
by: Handa Robert J, et al.
Published: (2004)

Cytochrome P450arom, androgen and estrogen receptors in pig sperm
by: Panza Rocco, et al.
Published: (2007)

Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors
by: Fabio Augusto Ito, et al.
Published: (2009)

A study of androgen and estrogen receptors α, β in skin tags
by: El Safoury Omar, et al.
Published: (2010)